Release Date: 22/04/16 16:35 Summary: Ceasing to be a substantial holder-GXY.AX Price Sensitive: No Download Document 70.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%